UBS Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $577M | Sell |
|
|||||
|
2025
Q1 | $604M | Sell |
|
|||||
|
2024
Q4 | $717M | Buy |
|
|||||
|
2024
Q3 | $673M | Buy |
|
|||||
|
2024
Q2 | $558M | Buy |
|
|||||
|
2024
Q1 | $461M | Buy |
|
|||||
|
2023
Q4 | $433M | Buy |
|
|||||
|
2023
Q3 | $488M | Sell |
|
|||||
|
2023
Q2 | $604M | Sell |
|
|||||
|
2023
Q1 | $760M | Buy |
|
|||||
|
2022
Q4 | $917M | Buy |
|
|||||
|
2022
Q3 | $652M | Sell |
|
|||||
|
2022
Q2 | $895M | Buy |
|
|||||
|
2022
Q1 | $869M | Sell |
|
|||||
|
2021
Q4 | $1.03B | Buy |
|
|||||
|
2021
Q3 | $744M | Buy |
|
|||||
|
2021
Q2 | $667M | Sell |
|
|||||
|
2021
Q1 | $681M | Sell |
|
|||||
|
2020
Q4 | $764M | Buy |
|
|||||
|
2020
Q3 | $658M | Buy |
|
|||||
|
2020
Q2 | $533M | Sell |
|
|||||
|
2020
Q1 | $559M | Sell |
|
|||||
|
2019
Q4 | $822M | Sell |
|
|||||
|
2019
Q3 | $823M | Sell |
|
|||||
|
2019
Q2 | $999M | Buy |
|
|||||
|
2019
Q1 | $814M | Sell |
|
|||||
|
2018
Q4 | $912M | Sell |
|
|||||
|
2018
Q3 | $926M | Sell |
|
|||||
|
2018
Q2 | $796M | Buy |
|
|||||
|
2018
Q1 | $742M | Sell |
|
|||||
|
2017
Q4 | $794M | Buy |
|
|||||
|
2017
Q3 | $735M | Buy |
|
|||||
|
2017
Q2 | $683M | Buy |
|
|||||
|
2017
Q1 | $678M | Buy |
|
|||||
|
2016
Q4 | $562M | Buy |
|
|||||
|
2016
Q3 | $563M | Buy |
|
|||||
|
2016
Q2 | $531M | Sell |
|
|||||
|
2016
Q1 | $458M | Sell |
|
|||||
|
2015
Q4 | $579M | Buy |
|
|||||
|
2015
Q3 | $498M | Sell |
|
|||||
|
2015
Q2 | $568M | Buy |
|
|||||
|
2015
Q1 | $545M | Sell |
|
|||||
|
2014
Q4 | $673M | Buy |
|